Mind Medicine (MNMD) has released an update.
Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, is set to engage in major industry events come June 2024. The company will discuss challenges in neuropsychiatric drug innovation at the BIO International Convention in San Diego and hold investor meetings at the Jefferies Global Healthcare Conference in New York.
For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.
